Sun Pharmaceutical Industries Ltd (SUN.BO)
18 May 2018
May 4 Indian shares dropped on Friday tracking global equity markets, while IT and pharma stocks pulled down the indexes, ahead of elections in key southern state of Karnataka.
MEDIA-Shanghvi's daughter to head consumer healthcare business at Sun Pharmaceutical Industries - Economic Times
- Note: Reuters has not verified this story and does not vouch for its accuracy
* UNIT RAISED STAKE IN RANBAXY MALAYSIA VIA FURTHER PURCHASE OF 394,404 SHARES OF RANBAXY MALAYSIA
Apr 5 Following are the details of deals in Indian Commercial Papers reported on Clearcorp F-TRAC Platform. ISIN DESCRIPTION MATURITY WTG AVG WTG AVG NO OF TRADED LAST TRADED DATE PRICE YLD% TRADES VALUE* PRICE YIELD ============ ============ ======== ======= ======= ====== ===== =============== INE704I14AZ2 BARCLAYS INVEST 88D 13-Apr-18 99.8573 6.5200 3 115 99.8573
Apr 3 Following are the details of deals in Indian Commercial Papers reported on Clearcorp F-TRAC Platform. ISIN DESCRIPTION MATURITY WTG AVG WTG AVG NO OF TRADED LAST TRADED DATE PRICE YLD% TRADES VALUE* PRICE YIELD ============ ============ ======== ======= ======= ====== ===== =============== INE660N14AH4 S. D. CORPORATION 90D 4-Apr-18 99.9773 8.2874 1 7 99.9773
** Shares of drugmaker Sun Pharmaceutical Industries Ltd rise as much as 3.27 pct to 521 rupees
* CO GETS U.S. FDA APPROVAL OF ILUMYA (TILDRAKIZUMAB-ASMN) FOR TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS Source text - http://bit.ly/2HRX8j1 Further company coverage:
** Sun Pharmaceutical Industries' Halol drug manufacturing plant may need four - six months to be cleared by the U.S. Food and Drug Administration (FDA), Credit Suisse analysts write in a note
BRIEF-Sun Pharmaceutical Industries Says U.S. FDA Issued Form 483 With 3 Observations For Halol Facility
* SUN PHARMACEUTICAL INDUSTRIES -U.S. FDA CONDUCTED GMP INSPECTION OF HALOL FACILITY (GUJARAT, INDIA) FROM FEBRUARY 12-23, 2018
India's largest drugmaker Sun Pharmaceutical Industries Ltd reported a 75 percent plunge in third-quarter net profit on Wednesday as pricing pressures in the United States, its biggest market, hit sales.